Cargando…

Long COVID in children and adolescents

Although acute COVID-19 has been milder in children and young people compared with adults, there is a concern that they may suffer persistent symptoms. There is a need to define the clinical phenotype, determine those most at risk, the natural course of the condition and evaluate preventive and ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephenson, Terence, Shafran, Roz, Ladhani, Shamez N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553244/
https://www.ncbi.nlm.nih.gov/pubmed/36098262
http://dx.doi.org/10.1097/QCO.0000000000000854
_version_ 1784806425509232640
author Stephenson, Terence
Shafran, Roz
Ladhani, Shamez N.
author_facet Stephenson, Terence
Shafran, Roz
Ladhani, Shamez N.
author_sort Stephenson, Terence
collection PubMed
description Although acute COVID-19 has been milder in children and young people compared with adults, there is a concern that they may suffer persistent symptoms. There is a need to define the clinical phenotype, determine those most at risk, the natural course of the condition and evaluate preventive and therapeutic strategies for both mental health and physical symptoms. RECENT FINDINGS: More recent studies with control groups reported a lower prevalence of persistent symptoms in children and young people exposed to SARS-CoV-2. A systematic review and meta-analysis found that the frequency of the majority of reported persistent symptoms is similar in SARS-CoV-2 positive cases and controls. Children and young people infected with SARS-COV-2 had small but significant increases in persisting cognitive difficulties, headache and loss of smell. Factors associated with persisting, impairing symptoms include increased number of symptoms at the time of testing, female sex, older age, worse self-rated physical and mental health, and feelings of loneliness preinfection. SUMMARY: This review highlights the importance of a control group in studies following SARS-CoV-2 infection, the need for case definitions and research to understand the outcomes of long COVID in children and young people.
format Online
Article
Text
id pubmed-9553244
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95532442022-10-19 Long COVID in children and adolescents Stephenson, Terence Shafran, Roz Ladhani, Shamez N. Curr Opin Infect Dis PAEDIATRIC AND NEONATAL INFECTIONS: Edited by Scott James Although acute COVID-19 has been milder in children and young people compared with adults, there is a concern that they may suffer persistent symptoms. There is a need to define the clinical phenotype, determine those most at risk, the natural course of the condition and evaluate preventive and therapeutic strategies for both mental health and physical symptoms. RECENT FINDINGS: More recent studies with control groups reported a lower prevalence of persistent symptoms in children and young people exposed to SARS-CoV-2. A systematic review and meta-analysis found that the frequency of the majority of reported persistent symptoms is similar in SARS-CoV-2 positive cases and controls. Children and young people infected with SARS-COV-2 had small but significant increases in persisting cognitive difficulties, headache and loss of smell. Factors associated with persisting, impairing symptoms include increased number of symptoms at the time of testing, female sex, older age, worse self-rated physical and mental health, and feelings of loneliness preinfection. SUMMARY: This review highlights the importance of a control group in studies following SARS-CoV-2 infection, the need for case definitions and research to understand the outcomes of long COVID in children and young people. Lippincott Williams & Wilkins 2022-10 2022-08-03 /pmc/articles/PMC9553244/ /pubmed/36098262 http://dx.doi.org/10.1097/QCO.0000000000000854 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle PAEDIATRIC AND NEONATAL INFECTIONS: Edited by Scott James
Stephenson, Terence
Shafran, Roz
Ladhani, Shamez N.
Long COVID in children and adolescents
title Long COVID in children and adolescents
title_full Long COVID in children and adolescents
title_fullStr Long COVID in children and adolescents
title_full_unstemmed Long COVID in children and adolescents
title_short Long COVID in children and adolescents
title_sort long covid in children and adolescents
topic PAEDIATRIC AND NEONATAL INFECTIONS: Edited by Scott James
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553244/
https://www.ncbi.nlm.nih.gov/pubmed/36098262
http://dx.doi.org/10.1097/QCO.0000000000000854
work_keys_str_mv AT stephensonterence longcovidinchildrenandadolescents
AT shafranroz longcovidinchildrenandadolescents
AT ladhanishamezn longcovidinchildrenandadolescents